REGIS NU641 CLINICAL ADV PHARMACOLOGY 2025
QUESTIONS WITH SOLUTIONS GUARANTEE A+
✔✔Treatment algorithm for symptomatic bacterial vaginosis - ✔✔First line - Flagyl (PO)
Second line - Cream (Vaginal)
Third line - Clindamycin
✔✔Treatment for gonorrhea - ✔✔Ceftriaxone (hepatic function) cefotaxime for those
with hepatic impairment
✔✔Treatment for Chlamydia - ✔✔Amoxicillin, then nitrofurantoin
✔✔Patient education for HIV medications (How they need to take them) - ✔✔
✔✔Postmenopausal women with an intact uterus should not be prescribed -
✔✔estrogen alone s/t risk of endometrial hyperplasia and endometrial cancer
✔✔SERMs (selective estrogen receptor modulators) - ✔✔Raloxifene - Prevention of
osteoporosis in menopausal women; Invasive breast cancer risk reduction (females);
Mimics estrogen beneficial bone sparing properties without affecting the uterus or
breasts
✔✔Treatment algorithm for dysmenorrhea - ✔✔NSAIDs
✔✔First line treatments for both types of pediatric diabetes
(Type I & Type II) - ✔✔Type I - Insulin
Type II - (Not treated under 10 years old) Diet and exercise
✔✔Treatment for constipation in pregnant patients - ✔✔Fiber base product, Fluid,
exercise, Metamucil, probiotics could be helpful
✔✔Treatment for constipation in elderly patients - ✔✔Lactulose or MiraLAX
✔✔Autoimmune impact to beta cells in Type I DM - ✔✔Destroys them and cause
absolute dependence of insulin
✔✔Levothyroxine (T4) - ✔✔First line treatment of hypothyroidism in general patients
✔✔Liothyronine (T3) - ✔✔First line of treatment of hypothyroidism in CV patients
✔✔the treatment goal for thyroid disorders - ✔✔correcting hypermetabolic state
✔✔Monitoring of Hyperthyroidism - ✔✔TSH and T4 Levels to the patient reaches a
stable euthyroid state this may take 6 to 8 weeks
, ✔✔Long term hyperthyroidism - ✔✔leads to increase CHF and increase in osteoporosis
✔✔Treatment of hypoglycemia - ✔✔15g CHO from glucose tablets, 4 oz fruit juice, 8 oz
of milk, half can of soda, or sugar
wait 15 minutes <70mg give another 15g
✔✔signs and symptoms of hypoglycemia - ✔✔reduced cognition, tremors, diaphoresis,
weakness, hunger, headache, irritability, seizure
✔✔Two categories of monitoring that are needed for patients with DM - ✔✔Blood
glucose in target range and signs of complications such as DKA in Type I (acute) and
chronic ones like nephropathy, retinopathy, peripheral and gastrointestinal
neuropathies, HTN, CV disease and dyslipidemia.
✔✔ACEIs are beneficial in DM patients - ✔✔They increase the renal function by
regulating the patient's blood pressure
✔✔Glucophage (metformin) - ✔✔First-line oral diabetic agent
✔✔Glucophage (metformin) side effects - ✔✔abdominal bloating, diarrhea, nausea,
vomiting, and an unpleasant metallic taste; vitamin B 12 deficiency; headache
✔✔the utility of protein restriction in ESRD patients - ✔✔A modest benefit of slowing
disease progression has been demonstrated by reducing the urinary protein excretion
✔✔Gabapentin (Neurontin) - ✔✔used for neuropathic pain
✔✔ACE inhibitors ("PRIL" Captopril, Enalapril, Afosiopril) - ✔✔cardiovascular drugs that
should be prescribed in diabetic patients (Type II)
✔✔Interactions with cholinergic blockers - ✔✔Drugs with a narrow therapeutic range
given orally may not stay in the GI tract long enough to produce an action
✔✔Pt is dx with depression and has been taking paroxetine (Paxil) PO daily x 2 weeks
with no relief what should be done - ✔✔Continue therapy
✔✔Pt on dx with depression is on SSRI sertraline (Zoloft) 100mg PO daily for 2 years
and want to stop taking it; what should be done - ✔✔Slowly taper down the dose until
off
✔✔This is considered true after reexamination of the women's health study which has
modified guidelines for the use of estrogen in menopause. - ✔✔Supplemental for the
QUESTIONS WITH SOLUTIONS GUARANTEE A+
✔✔Treatment algorithm for symptomatic bacterial vaginosis - ✔✔First line - Flagyl (PO)
Second line - Cream (Vaginal)
Third line - Clindamycin
✔✔Treatment for gonorrhea - ✔✔Ceftriaxone (hepatic function) cefotaxime for those
with hepatic impairment
✔✔Treatment for Chlamydia - ✔✔Amoxicillin, then nitrofurantoin
✔✔Patient education for HIV medications (How they need to take them) - ✔✔
✔✔Postmenopausal women with an intact uterus should not be prescribed -
✔✔estrogen alone s/t risk of endometrial hyperplasia and endometrial cancer
✔✔SERMs (selective estrogen receptor modulators) - ✔✔Raloxifene - Prevention of
osteoporosis in menopausal women; Invasive breast cancer risk reduction (females);
Mimics estrogen beneficial bone sparing properties without affecting the uterus or
breasts
✔✔Treatment algorithm for dysmenorrhea - ✔✔NSAIDs
✔✔First line treatments for both types of pediatric diabetes
(Type I & Type II) - ✔✔Type I - Insulin
Type II - (Not treated under 10 years old) Diet and exercise
✔✔Treatment for constipation in pregnant patients - ✔✔Fiber base product, Fluid,
exercise, Metamucil, probiotics could be helpful
✔✔Treatment for constipation in elderly patients - ✔✔Lactulose or MiraLAX
✔✔Autoimmune impact to beta cells in Type I DM - ✔✔Destroys them and cause
absolute dependence of insulin
✔✔Levothyroxine (T4) - ✔✔First line treatment of hypothyroidism in general patients
✔✔Liothyronine (T3) - ✔✔First line of treatment of hypothyroidism in CV patients
✔✔the treatment goal for thyroid disorders - ✔✔correcting hypermetabolic state
✔✔Monitoring of Hyperthyroidism - ✔✔TSH and T4 Levels to the patient reaches a
stable euthyroid state this may take 6 to 8 weeks
, ✔✔Long term hyperthyroidism - ✔✔leads to increase CHF and increase in osteoporosis
✔✔Treatment of hypoglycemia - ✔✔15g CHO from glucose tablets, 4 oz fruit juice, 8 oz
of milk, half can of soda, or sugar
wait 15 minutes <70mg give another 15g
✔✔signs and symptoms of hypoglycemia - ✔✔reduced cognition, tremors, diaphoresis,
weakness, hunger, headache, irritability, seizure
✔✔Two categories of monitoring that are needed for patients with DM - ✔✔Blood
glucose in target range and signs of complications such as DKA in Type I (acute) and
chronic ones like nephropathy, retinopathy, peripheral and gastrointestinal
neuropathies, HTN, CV disease and dyslipidemia.
✔✔ACEIs are beneficial in DM patients - ✔✔They increase the renal function by
regulating the patient's blood pressure
✔✔Glucophage (metformin) - ✔✔First-line oral diabetic agent
✔✔Glucophage (metformin) side effects - ✔✔abdominal bloating, diarrhea, nausea,
vomiting, and an unpleasant metallic taste; vitamin B 12 deficiency; headache
✔✔the utility of protein restriction in ESRD patients - ✔✔A modest benefit of slowing
disease progression has been demonstrated by reducing the urinary protein excretion
✔✔Gabapentin (Neurontin) - ✔✔used for neuropathic pain
✔✔ACE inhibitors ("PRIL" Captopril, Enalapril, Afosiopril) - ✔✔cardiovascular drugs that
should be prescribed in diabetic patients (Type II)
✔✔Interactions with cholinergic blockers - ✔✔Drugs with a narrow therapeutic range
given orally may not stay in the GI tract long enough to produce an action
✔✔Pt is dx with depression and has been taking paroxetine (Paxil) PO daily x 2 weeks
with no relief what should be done - ✔✔Continue therapy
✔✔Pt on dx with depression is on SSRI sertraline (Zoloft) 100mg PO daily for 2 years
and want to stop taking it; what should be done - ✔✔Slowly taper down the dose until
off
✔✔This is considered true after reexamination of the women's health study which has
modified guidelines for the use of estrogen in menopause. - ✔✔Supplemental for the
